The higher expression of biomarkers such as interleukin-6 (IL-6), intercellular adhesion molecule (ICAM), and CRP, which leads to inflammation, fibrosis, and RAAS activation, is involved in the development of HF in patients with RA [5]. Here, CRP is linked to rheumatoid arthritis.